Compare DCOY & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCOY | MYSZ |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | Israel |
| Employees | 11 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.5M |
| IPO Year | N/A | 2017 |
| Metric | DCOY | MYSZ |
|---|---|---|
| Price | $8.15 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | 8.5K | ★ 26.1K |
| Earning Date | 05-16-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,000.00 |
| Revenue This Year | N/A | $41.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 125.40 |
| 52 Week Low | $0.53 | $0.48 |
| 52 Week High | $9.09 | $1.65 |
| Indicator | DCOY | MYSZ |
|---|---|---|
| Relative Strength Index (RSI) | 73.68 | 59.97 |
| Support Level | $5.28 | $0.61 |
| Resistance Level | $9.09 | $0.68 |
| Average True Range (ATR) | 0.67 | 0.04 |
| MACD | 0.34 | 0.01 |
| Stochastic Oscillator | 91.62 | 79.15 |
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.